Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04213391 |
Recruitment Status : Unknown
Verified May 2019 by Second Affiliated Hospital, School of Medicine, Zhejiang University.
Recruitment status was: Recruiting
First Posted : December 30, 2019
Last Update Posted : May 12, 2020
|
Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Information provided by (Responsible Party):
Second Affiliated Hospital, School of Medicine, Zhejiang University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | November 1, 2022 |
Estimated Study Completion Date : | December 1, 2022 |
Publications: